Tilray Inc (TLRY)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $359.12M
Last updated: Nov 17, 2026 at 11:06 AM ET
Tilray Inc (TLRY) Earnings: Report Dates and Results
Tilray (TLRY) is expected to report earnings on Jan 6, 2027. In the quarter ended Aug 31, 2026, Tilray reported EPS of -$0.32, below the -$0.19 estimate. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
TLRY has an expected report date of Jan 6, 2027. No consensus estimate is on file yet for the quarter ending Nov 30, 2026.
TLRY Earnings Call
The latest TLRY earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 31 quarters below that had an estimate, TLRY beat 11 and missed 20. Revenue for the quarter ended Aug 31, 2026 was $257.15M, up 22.7% from $209.50M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | -$0.32 | -$0.19 | -$0.32 - $0.04 | -68.42% | Miss | N/A | 2 | 0 up, 0 down | Oct 8, 2026 | $257.15M |
| May 31, 2026 | -$0.43 | -$0.02 | N/A | N/A | N/A | -2250.0% | 1 | 1 up, 0 down | Jul 28, 2026 | $281.71M |
| Feb 28, 2026 | $0.02 | $0.07 | $0.07 - $0.07 | -71.43% | Miss | N/A | 1 | 0 up, 1 down | Apr 1, 2026 | $206.73M |
| Nov 30, 2025 | -$0.02 | -$0.02 | N/A | -8.11% | Miss | N/A | 1 | 0 up, 1 down | Jan 8, 2026 | $217.51M |
| Aug 31, 2025 | $0.00 | -$0.04 | N/A | +99.26% | Beat | N/A | 1 | 0 up, 0 down | Oct 9, 2025 | $209.50M |
| May 31, 2025 | $0.02 | -$0.02 | N/A | +200.00% | Beat | N/A | 1 | 0 up, 1 down | Jul 28, 2025 | $224.53M |
| Feb 28, 2025 | -$0.87 | -$0.33 | -$0.90 - $0.20 | -163.36% | Miss | N/A | 3 | 0 up, 0 down | Apr 8, 2025 | $185.78M |
| Nov 30, 2024 | -$0.03 | -$0.13 | -$0.30 - $0.00 | +76.92% | Beat | N/A | 3 | 0 up, 0 down | Jan 10, 2025 | $210.95M |
| Aug 31, 2024 | -$0.10 | -$0.30 | -$0.90 - -$0.10 | +66.67% | Beat | N/A | 5 | 1 up, 0 down | Oct 10, 2024 | $200.04M |
| May 31, 2024 | -$0.04 | -$0.02 | -$0.04 - -$0.01 | -100.00% | Miss | N/A | 5 | 0 up, 0 down | Jul 29, 2024 | $229.88M |
| Feb 29, 2024 | -$0.12 | -$0.47 | -$1.00 - -$0.40 | +74.47% | Beat | N/A | 6 | 0 up, 0 down | Apr 9, 2024 | $188.34M |
| Nov 30, 2023 | -$0.60 | -$0.47 | -$0.70 - -$0.40 | -27.66% | Miss | N/A | 5 | 0 up, 0 down | Jan 9, 2024 | $193.77M |
| Aug 31, 2023 | -$0.91 | -$0.57 | -$0.80 - -$0.30 | -59.65% | Miss | N/A | 5 | 0 up, 0 down | Oct 4, 2023 | $239.67M |
| May 31, 2023 | -$0.15 | -$0.05 | -$0.07 - -$0.03 | -200.00% | Miss | N/A | 6 | 0 up, 0 down | Jul 26, 2023 | $184.19M |
| Feb 28, 2023 | -$0.40 | -$0.58 | -$0.70 - -$0.20 | +31.03% | Beat | -154.1% | 10 | 1 up, 0 down | Apr 10, 2023 | $145.59M |
| Nov 30, 2022 | -$0.60 | -$0.54 | -$0.90 - -$0.30 | -11.11% | Miss | -2100.0% | 10 | 1 up, 0 down | Jan 9, 2023 | $144.14M |
| Aug 31, 2022 | -$0.80 | -$0.70 | N/A | -14.29% | Miss | N/A | N/A | 0 up, 1 down | Oct 7, 2022 | $153.21M |
| May 31, 2022 | -$0.90 | -$0.80 | -$1.00 - -$0.50 | -12.50% | Miss | -433.3% | 9 | 0 up, 1 down | Jul 28, 2022 | $153.32M |
| Feb 28, 2022 | $0.74 | -$0.79 | N/A | +193.67% | Beat | N/A | N/A | 0 up, 0 down | Apr 6, 2022 | $151.87M |
| Nov 30, 2021 | $0.03 | -$0.77 | N/A | +103.90% | Beat | N/A | 1 | 0 up, 0 down | Jan 10, 2022 | $155.15M |
| Aug 31, 2021 | -$0.70 | -$0.67 | -$1.20 - -$0.50 | -4.48% | Miss | N/A | 5 | N/A | Oct 7, 2021 | $168.02M |
| May 31, 2021 | $0.27 | -$0.11 | N/A | +345.45% | Beat | N/A | N/A | N/A | Jul 28, 2021 | $183.81M |
| Feb 28, 2021 | -$0.06 | -$0.32 | N/A | +80.95% | Beat | N/A | N/A | N/A | May 10, 2021 | $100.62M |
| Nov 30, 2020 | -$0.45 | -$0.15 | N/A | -200.00% | Miss | N/A | N/A | N/A | Feb 17, 2021 | $120.57M |
| Aug 31, 2020 | -$0.02 | -$0.02 | N/A | +4.76% | Beat | N/A | N/A | N/A | Nov 9, 2020 | $51.41M |
| May 31, 2020 | -$0.65 | -$0.27 | N/A | -140.74% | Miss | N/A | N/A | N/A | Aug 10, 2020 | $72.61M |
| Feb 29, 2020 | -$1.05 | -$0.45 | N/A | -133.33% | Miss | N/A | N/A | N/A | May 11, 2020 | $92.77M |
| Aug 31, 2019 | -$0.34 | -$0.30 | N/A | -13.33% | Miss | N/A | N/A | N/A | Nov 12, 2019 | $71.16M |
| May 31, 2019 | -$0.36 | -$0.25 | N/A | -44.00% | Miss | N/A | N/A | N/A | Aug 13, 2019 | $70.59M |
| Feb 28, 2019 | -$0.35 | -$0.27 | N/A | -29.63% | Miss | N/A | N/A | N/A | May 14, 2019 | $17.21M |
| Aug 31, 2018 | -$0.20 | -$0.12 | N/A | -66.67% | Miss | N/A | N/A | N/A | Nov 13, 2018 | $10.05M |
| May 31, 2018 | -$0.17 | -$0.08 | N/A | -112.50% | Miss | N/A | N/A | N/A | Aug 28, 2018 | $6.90M |
| Feb 28, 2018 | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 19, 2018 | $6.25M |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended May 31, 2026 was -$0.43, after -$0.98 the year before. It was -$0.26 for the year ended May 31, 2018, the oldest of the 9 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| May 31, 2026 | -$0.43 | N/A |
| May 31, 2025 | -$0.98 | N/A |
| May 31, 2024 | -$1.67 | N/A |
| May 31, 2023 | -$1.95 | N/A |
| May 31, 2022 | -$0.83 | N/A |
| May 31, 2021 | -$0.26 | N/A |
| May 31, 2020 | -$2.04 | N/A |
| May 31, 2019 | -$0.91 | N/A |
| May 31, 2018 | -$0.26 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,200 words across 11 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 6,240 | 11 | |
| 2026Q2 | Jun 30, 2026 | 6,863 | 9 | |
| 2026Q1 | Mar 31, 2026 | 5,399 | 11 | |
| 2025Q4 | Dec 31, 2025 | 9,134 | 11 | |
| 2025Q3 | Sep 30, 2025 | 10,004 | 11 | |
| 2025Q2 | Jun 30, 2025 | 7,455 | 11 | |
| 2025Q1 | Mar 31, 2025 | 9,061 | 13 | |
| 2024Q4 | Dec 31, 2024 | 9,370 | 10 |
2026Q3 Earnings Call
Opening remarks
Berrin Noorata Chief Communications and Corporate Affairs Officer Thank you, operator, and good morning, everyone. By now, you should have access to the earnings press release, which is available on the Investors section of the Tilray Brands website at tilray.com and has been filed with the SEC and OSC. Please note that during today's call, we will be referring to various non-GAAP financial measures that can provide useful information for investors. However, the presentation of this information is not intended to be considered in isolation or as a substitute for the financial information presented in accordance with GAAP. The earnings press release contains a reconciliation of each non-GAAP financial measure to the most comparable measure prepared in accordance with GAAP. In addition, we will be making numerous forward-looking statements during our remarks and in response to your questions. These statements are based on our current expectations and beliefs and involve known and unknown risks and uncertainties, which may prove to be incorrect. Actual results could differ materially from those described in those forward-looking statements. The text in our earnings press release includes many of the risks and uncertainties associated with such forward-looking statements. Today, we will be hearing from key members of our senior leadership team, beginning with Irwin Simon, Chairman and Chief Executive Officer, who will provide opening remarks and commentary followed by Carl Merton, Chief Financial Officer, who will review our financial results for the third quarter of fiscal year 2026. And now I'd like to turn the call over to Tilray Brands' Chairman and CEO, Irwin Simon.
Irwin Simon Chairman and Chief Executive Officer Thank you, Berrin, and good morning, everyone. It's been an exciting year at Tilray Brands. We delivered a record quarter with continued international expansion across our platforms. I also want to briefly highlight our BrewDog acquisition. When you have good news, you go to the tallest building and scream it and don't wait. This transaction positions Tilray at approximately $1.2 billion global revenue company on an annualized basis and meaningfully strengthens our long-term growth profile. I've done over 100 acquisitions in my life, and I've never received more calls, congratulations and a brand with more awareness on a global basis, which helps Tilray to be at the forefront around the world. Since 2019, we have transformed the company from a Canadian cannabis business with approximately $50 million in revenue to a global lifestyle consumer products company approaching over $1 billion in revenue on an annualized basis, providing the strength and effectiveness of our strategy and our execution going forward. We are building a diversified global platform grounded in a long-term vision of bringing people together through meaningful connection. With a strong team and clear priorities, we remain confident in our path forward.
Frequently Asked Questions About TLRY
When is Tilray's next earnings date?
Tilray's next earnings report is expected for Jan 6, 2027.
Did TLRY beat earnings estimates last quarter?
No. Tilray reported EPS of -$0.32 for the quarter ended Aug 31, 2026, below the -$0.19 estimate by 68.42%.
How often does TLRY beat earnings estimates?
Tilray beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of +16.44%.
TLRY pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors